Kidney transplant study halted: blood Test's role unclear
NCT ID NCT01424345
First seen Mar 26, 2026 · Last updated May 22, 2026 · Updated 7 times
Summary
This study looked at whether a blood test called ImmuKnow could help doctors adjust anti-rejection drugs in new kidney transplant patients to prevent infections and rejection. Only 4 people took part before the study was stopped early. The goal was to see if using the test led to fewer infections compared to standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT IMMUNOSUPPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CAMC
Charleston, West Virginia, 25301, United States
Conditions
Explore the condition pages connected to this study.